Figure 5C showed that total copies of KRAS transcripts (mutated KRAS + wild‐type KRAS) were significantly higher in the EVs captured from plasma samples of pancreatic cancer patients compared to the total copies of KRAS transcripts in EVs captured from plasma samples of healthy donors (P = 0.01). This evidence concerns the gene KRAS and familial pancreatic carcinoma.